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1 
 Abstract 
 
Microglia represent an emerging enigma in the field of neurobiology. While the 
study of these cells previously focused on their actions in an immune response, it is 
becoming evident that they must play a significant role in the development and 
maintenance of a healthy brain. In order to study these phenomena, it is necessary to 
test new techniques in order to study these systems. One such technique is the cre-lox 
system. Using cre recombinase, it may be possible to selectively eliminate microglia in 
the brain through the excision of the CSF1R gene, while simultaneously preserving 
tissue macrophage populations. In this experiment, microglia were successfully 
depleted without causing any significant disruption to tissue macrophages located in the 
liver.  
 
Introduction 
 
  The function of microglia in the central nervous system (CNS) represents an 
intriguing enigma in the field of neurobiology. Previously thought to have function only in 
the immune response defending the CNS, these macrophages have been discovered to 
play a part in multiple processes regarding the defense and development of the CNS. 
Multifaceted as these cells are, their role in many of these processes is still being 
studied. Part of this investigation requires the testing and validation of individual 
techniques in order to further the ability to acquire definitive data on the observed 
variables. One avenue of microglia research seeks to demonstrate the effects on the 
CNS from of a loss of microglia in the organism. This experiment seeks to demonstrate 
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 the effectiveness of the floxing technique in order to eliminate microglia from the host 
CNS, without disrupting the presence of microglia in the rest of the organism.  
Microglia represent an important function as the exclusive macrophage CNS. As 
macrophages, these cells are designed to find foreign bodies in the vicinity and engulf 
them. This phagocytic  characteristic may be a key component in understanding the 
functions of microglia outside of the immune system. Normally this phagocytic capability 
is discussed in the context of how it comes into play in an immune response. In an 
immune response, these cells normally attack and engulf foreign material, digest it 
down into smaller components, and then present these components as antigens on the 
surface of the cell. (1) These antigens can then be recognized by T cells, which will 
proliferate to combat whatever assailants are recognized by the macrophage. Microglia 
perform this role just as any other macrophage might.  
So what makes microglia different from other macrophages? The first important 
disparity differentiating microglia from other macrophages is the point of origin. While all 
macrophages begin replication in the yolk sac before birth, almost all macrophages 
proliferate in the red bone marrow and are distributed to the various tissues of the body. 
Microglia, on the other hand, are generated solely in the yolk sac and are regenerated 
from the existing colony in the CNS. While most macrophages are derived from 
monocytes, Microglia develop from erythromyeloid progenitors in the yolk sac of the 
developing organism. In mice, around embryonic day 8 these embryonic microglia 
migrate to and colonize the CNS. This early colonization of the CNS is interesting in the 
scope of observing how microglia are involved in the development and organization of 
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 neuronal tissue in the brain. After the organism is born, no more microglia are being 
delivered to the CNS, and the present population becomes self sustaining. (2) It is still 
unclear as to how the microglia maintain their population. Microglia may simply undergo 
regular  cell division, but it is also possible that there is a specific progenitor class of 
microglia that contribute to the production of new cells, or there may even be a specific 
state the microglia undergo in which they can proliferate. (21)  
In addition to the differing origin of microglia, they also have a unique range of 
functions in the CNS as well. There are many speculated functions for the microglia, but 
repeated studies indicate a few likely purposes of the cells. One extremely important 
finding is the implication of microglia in the process of synaptic pruning. (3) Synaptic 
pruning is a crucial housekeeping activity in the brain that prioritizes important neuronal 
connections and eliminates superfluous synaptic connections. This process is crucial in 
optimizing CNS efficiency. In synaptic pruning, when synapse connecting two neurons 
is not used frequently enough it is eliminated in favor of strengthening the synapses that 
are more frequently used. (4) This process is important in allowing the brain to function 
at it’s normal capacity. Errors in this process have been linked to multiple neurological 
conditions such as schizophrenia. Proper synaptic pruning is necessary in maintaining 
the efficiency of the brain, being necessary to retain important information and eliminate 
superfluous connections. In order for this to happen, some sort of signaling pathway 
and subsequent mechanism must exist in order to recognize and eliminate the unused 
synapse. This is where microglia may participate in the process.  
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 There is a classification of proteins known as chemokines that fulfill significant 
signaling roles in the body. One specific chemokine pathway of interest manages the 
interactions between microglia and the surrounding neurons. The two protein 
components of this pathway are CX3CR1, located in microglia, and CX3CL1, also 
known as fractalkine, located in neurons. These two represent a receptor-ligand pair in 
a complex series of interactions known as the fractalkine signaling pathway. This is the 
proposed system through which microglia interact with neurons and their synapses, 
allowing them to regulate synaptic pruning, initiating cell death, and organizing neuronal 
growth and wiring. (5)(6) In the process of synaptic pruning, studies provide evidence 
that the expression of CX3CL1 on the surface of synapses and in the extracellular 
space may recruit microglia to the site to either strengthen or eliminate the connection. 
Engulfment assays were performed to determine whether or not the microglia were 
partaking in phagocytic activity against the neurons to consume and digest the unused 
synapses. Evidence from these experiments does in fact incriminate microglia as the 
probable instrument for this process. (7) (8) This is crucial evidence supporting claims 
and research asserting microglial involvement in neuroplasticity.  
Related to this process of synaptic pruning, Microglia are also shown to be 
involved in the structuring and “wiring” of neurons as well. This may be a very similar 
process involving microglias’ phagocytic ability, however microglia have also been 
shown to interact with neurons via multiple trophic factors. (9) Though the exact 
mechanism may be unclear, microglia are absolutely necessary for the healthy wiring 
and organisation of the CNS. Multiple studies have been performed to demonstrate that 
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 a loss of microglia has a direct negative impact on the brain. One method used to 
demonstrate this is by eliminating the macrophage proliferation gene from a mouse’s 
genome. (10) 
This gene is expressed by all macrophages, and is responsible for the generation 
of the colony stimulating factor 1 receptor, or CSF-1R. CSF-1R is necessary for 
macrophages to receive the signal to begin proliferation. (11) Without this gene, 
microglia will not express this receptor and will not proliferate. Despite their differences, 
microglia share this system with other macrophages. This means that if CSF-1R is 
eliminated from the mouse genome, then microglia will not proliferate. When this is 
applied, the affected brains do not develop properly. Studies have shown that though 
the brain retains its normal relative size, the structures within the brain are disrupted. 
This evidence provides great support to the idea that microglia play a large role in the 
structural development of the brain. (10) However, using this technique does have 
ramifications and limitations. By eliminating CSF-1R, this prevents all macrophages in 
the body from replenishing. This causes compromises the immune response of the 
host, and generally leads to weakness and frailty of the subjects. The majority of 
subjects have a vastly reduced life span as well. (11) Since the disruption of this gene 
on the organismal scale has so many other effects, it makes it very difficult to study. It 
becomes extremely difficult to draw conclusions on any experiment that uses this 
technique, as there are so many other consequences that may be influencing the 
results. 
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 This is extremely problematic when trying to examine the long term effects of an 
absence of microglia, and eliminates the the ability to modulate when there are or aren’t 
microglia. For example, it would be impossible to see the effects of removing microglia 
from an already developed brain as the subject that has a CSF1R knockout, as the 
microglia will be consistently depleted from the start. In addition, since the results would 
not be indicative of a normal brain as the subject would have developed without 
microglia to aid in neuronal wiring. Specimens would also likely not survive long enough 
to provide useful subjects. One solution to this problem is to selectively eliminate 
CSF-1R primarily in microglia. 
This objective can be accomplished by using cre recombinase and loxP sites. 
This is a technique designed to selectively alter genes in cells that express another 
gene exclusive to the cell type. This mechanism relies on the protein cre recombinase 
(Cre). Cre is a protein originally isolated from a p1 bacteriophage that is responsible for 
genetic reconfiguration. What makes Cre such a useful tool is that it will only interact 
with DNA that is flanked by loxP sites. LoxP stands for locus of x-over (crossover) p1 
bacteriophage, and are regions of 34 base pairs containing symmetrical flanking regions 
of 13 base pairs and an asymmetrical region of 8 base pairs. (12) When two loxP sites 
flank a sequence of DNA, depending on their directions Cre can take a number of 
actions, including deletion, inversion, and translocation. Since loxP sites can be added 
into a subjects genome, this system makes Cre an invaluable resource in any 
conditional knockout research, and many studies have already proven it’s effectiveness. 
(13)  
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 In order to apply this to research of microglia, a few steps need to be taken. First, 
strains of mice must be created that have the CSF-1R gene with inwards facing loxP 
sites. This makes it so all macrophages in the mouse could be targeted by any present 
Cre. Secondly, mice must also be created that contain the gene for creating Cre 
recombinase. In order to only be expressed in the desired cells, the Cre gene must be 
attached to another gene that is expressed only in the desired cell type. In the case of 
microglia, one of the best options to use is the CX3CR1 gene. Since this gene is 
expressed solely in microglia, and in sufficient number, this makes it the ideal choice. In 
addition, the Cre gene must also be produced with an estrogen receptor that will be 
used as the activator for the Cre. This allows further modulation of when the Cre can 
excise the CSF-1R gene. Once the two strains of mice are created, they must be bred 
to have offspring containing both the flanked by loxP (floxed) CSF-1R gene, as well as 
the CX3CR1 Cre/er gene. The only genotype of these offspring that can have CSF-1R 
knocked out are those that are homozygous for the CSF-1R floxed gene, and 
heterozygous for the CX3CR1 Cre/er gene. They must be homozygous for the CSF-1R 
floxed gene as if only one copy of the gene can be removed, they can still produce the 
colony stimulating factor 1 receptor. The mice must be heterozygous for the CX3CR1 
Cre/er gene as a homozygous mouse as this can lead to certain toxic effects and 
unexpected genetic translocations. (12)  
Once these offspring are ready for testing, a catalyst needs to activate the Cre in 
order for it to enter the nucleus to perform it’s function. When expressed the Cre/er 
complex resides in the cytoplasm. When these mice are injected with tamoxifen, the 
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 tamoxifen reacts with the estrogen receptor on the Cre/er complex allowing it to relocate 
to the nucleus and perform it’s function. (12) Once there the Cre should excise the 
floxed gene, which in this case would render the microglia incapable of receiving the 
signal to proliferate.  
This technique has many useful applications in the field of microglia research, 
and it’s application provides our lab a few informative avenues of research. We hope to 
accomplish a few things by utilizing this technique. This first goal we set out to 
accomplish is to demonstrate the effectiveness of this technique in reducing and 
eliminating the population of microglia in the mouse CNS without eliminating 
macrophages in other organ systems. The second is to gain a more accurate estimate 
of the time required for the technique to eliminate a sufficient number of microglia in the 
mouse CNS. Further points of interest include using this technique to observe long term 
elimination of microglia in the mouse CNS without disrupting macrophages on the 
organismal level, as well as the examination of how and where microglia repopulate in 
the brain, as well as the time required to do so.  
 
Goals 
 
The goals of this experiment are based around the depletion of microglia and 
observing how they may repopulate in the brain. This experiment must show that the 
cre-lox system can cause significant depletion of microglia, without disrupting other 
tissue macrophages found elsewhere in the body. It should also provide preliminary 
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 data on where the microglia may begin to repopulate, and identify possible patterns for 
future investigation. 
 
Methods 
 
Overview: 
 
The goal of this experiment is to show that the Cre-Lox system can effectively 
eliminate microglia in the brain without significantly disrupting the populations of other 
tissue macrophages. In this experiment genetically modified mice from Jackson Labs 
bred to create mice of desired genotypes for these experiments. These mice were then 
injected over a series of days with tamoxifen to activate their cre recombinase. The 
mice were then retrieved and perfused at the desired timepoint. The brain as well as 
other tissues were retrieved for observation. The tissues were fixed using PFA, and 
then dehydrated with sucrose. The tissues were then sectioned on a microtome, and 
the gathered slices were used as the samples for imaging. Immunohistochemistry was 
used to fluorescently stain microglia in the tissues. These stained samples were then 
observed using confocal microscopy and epifluorescence microscopy. Microglia and 
macrophages were then counted in these tissues in various regions of the brain, and at 
multiple magnifications, using the program FIJI, a modified version of ImageJ.  
 
Breeding: 
 
Two strains of mice were acquired from Jackson Labs. One genotype of these 
mice contained the CSF1R gene with flanking LoxP sites, but no cre-recombinase. The 
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 Second strain of mice had a knock in of the cre-recombinase gene into the CX3CR1 
gene. These strains were then crossed, creating breeder mice containing both 
genotypes. These breeders were then bred to create mouse litters that contained the 3 
desired genotypes. The three desired genotypes for this experiment are the knockout 
genotype: CSF1R Fl/Fl, CX3CR1 er/+, the wild type control: CSF1R Fl/Fl, CX3CR1 +/+,, 
and the heterozygous control: CSF1R Fl/+, CX3CR1 er/+. The wild type control 
demonstrates that without the presence of cre, then the CSF1R gene still functions 
normally. The heterozygous control shows a double knockout of CSF1R is necessary to 
cause total depletion. Only mice of these 3 genotypes were used in the experiment.  
 
Paradigms:  
 
Two of the paradigms tested are presented in this evaluation. The first paradigm 
had mice of the desired genotypes being injected with tamoxifen at postnatal days 4 
through 8 (P4-P8), with retrieval and perfusion of these mice occurring on P10. The 
second paradigm consisted of mice that were injected days P1-P5, and retrieved and 
perfused on day P15. These paradigms were chosen to observe tissues at different time 
points post injection (2 days and 10 days,)  while still showing tissues from juvenile 
mice.  
 
Genotyping:  
 
Mice were tested for the desired genotypes using a combination of PCR, gel 
electrophoresis, and ultraviolet imaging.  
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 First mice were identified and tissue samples were gathered. To identify newborn 
mice, each had one or more of their paws tattooed to mark each individual with a unique 
identifier. Examples of this are tattooing just the right front paw, indicated by the 
designation RF, or right-front. These tattoos were performed by hand using a 30 gauge 
needle.  
Each mouse then had a tissue sample taken from it’s tail. Less than 1 cm of the 
end of the tail was removed to be used in the genotyping process. Immediately after tail 
snipping, pressure was applied to stop the bleeding (if any.)  
A tissue digest was then performed on these samples. This is to break down the 
tissue. Making access to the genetic code possible for genotyping. Tissue samples 
were subjected to 75 ul of 25nM NaOH/0.2 nM EDTA, and heated at 98 degrees C in a 
thermocycler for 1 hour. The reaction was then neutralized using 40 mM Tris-HCl. 
Tubes were then vortexed lightly to homogenize the solution. These samples were then 
ready for genotyping.  
Each sample was subjected to two sets of genotyping. One series tested for the 
presence of the CSF1R gene, and the other for the CX3CR1 gene. For this, a 
polymerase chain reaction, or PCR, was performed on each sample. PCR allows for the 
amplification of desired genes, replicating these sequences to quantities that can be 
effectively visualized on a gel. For each PCR reaction, there needs to be a sample to 
act as the template, polymerase to replicate the gene, primers to promote selective 
replication, and dNTPs to provide the transcript materials.For this experiment, 10 ul of 
working solution per sample were prepared for each set of genotyping. The working 
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 solution consisted of purified water, 2x Taq RED Master Mix, and the genotype specific 
primers. (see appendix) 10 ul of working solution was mixed with 2 ul of each sample 
solution. Positive, wild type, and negative controls were also used. The PCR reaction 
was then run in a thermocycler. The cycle sequence can be seen in  the appendix. 
 PCR results were then separated using gel electrophoresis. This technique 
involves running an electrical current through an agarose gel to separate the DNA by 
size. Since DNA has a negative charge, all the samples should move through the gel 
towards the positive charge. The gel is porous enough to allow the samples to move 
through it, while restricting movement enough to hold the samples long enough to allow 
separation of components. The DNA moving through the gel should separate based on 
it’s size, as the larger the sequence is the slower it will move through the gel. The gel 
used was a 1.5% agarose gel, diluted in TAE, with ethidium bromide. (See appendix) 
The ethidium bromide in the gel creates fluorescence in the presence of DNA, allowing 
for the visualization of the samples. The amplified genes should provide a high enough 
concentration to create a large contrast between the gene of interest and any 
background fluorescence, causing the created bands to glow much brighter than the 
surrounding gel. The gel was also run in a solution of 1x TAE, which provides a medium 
for the charge to travel to and through the gel.  
The PCR results were loaded into this gel, and the genes were separated by 
size. These results were visualized by exposing the gel to ultraviolet light. When 
ethidium bromide is exposed to ultraviolet light, it will fluoresce, allowing for visualization 
of DNA bands. The result shows bands for each sample. The distance these bands 
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 traveled were compared to the ladder containing DNA samples of known sizes, as well 
as positive and wild type control bands, to discern the genotype of the sample. If the 
sample generated two bands, that means that both the wild type version of the gene 
and the modified version of the gene were present for amplification, meaning the mouse 
is heterozygous for that gene. If the mouse had a single band, they would be 
homozygous for either the wild type of modified version of the gene. This band was 
compared to the positive and wild type control bands to discern which gene it 
represented.  
 
Tamoxifen Injections: 
 
Once the genotypes of the mice were confirmed, the mice of the desired 
genotypes were selected to participate in the 2 experimental paradigms. These mice 
were all to be injected with tamoxifen at the designated timepoints. For each injection 
the mice were injected with 50 ul of tamoxifen working solution. The tamoxifen working 
solution consists of 1 ug/ul tamoxifen dissolved in corn oil. This solution was prepared in 
a 5 ml eppendorf tube by diluting a stock solution of 20 ug/ul tamoxifen in corn oil. 
Preparation of the stock solution was originally done by sonicating the tamoxifen in the 
corn oil to dissolve the particles. However, this process led to a high mortality rate in the 
injected mice of all genotypes. One possible reason for this is the sonication probe may 
have sheared plastic from the side of the preparation tube into solution. It’s also 
possible that the heat of sonication could have altered the compounds in solution to 
become toxic. A new preparation method was devised in which tamoxifen was dissolved 
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 overnight in a rotator in an incubator. This led to a drastic decrease in mortality, and 
became the prefered method of preparation. (See appendix) 
When the mice were injected, they were held by the scruff of their neck and the 
tail. They were then injected intraperitoneally with tamoxifen using a 30 gauge needle. 
The injection site was always on the ventral posterior quadrant of the abdomen.  
 
Perfusions:  
 
When subject mice were of the appropriate age, they were retrieved for 
perfusion. Perfusion is a technique of flushing the cardiovascular system of blood with 
another solution. This process is important for two reasons. The first is that it removes 
blood that may contaminate the sample brains with cells from other parts of the body. 
The other reason is that it allows for the fixation of the brain using PFA. By inserting 
PFA into the brain using the cardiovascular system, more effective fixation can be 
performed. Tissue fixation using PFA is important as it helps prevent the degradation of 
the tissue. This is critical in preserving the tissue.  
For this process, mice were anesthetized using 2.5% avertin injections. (See 
appendix) Approximately 0.6-0.8 ml of avertin were injected to induce an unconscious 
state. Mice were tested for sensation before the dissection by squeezing the feet 
forcefully with forceps. Once it was guaranteed that the mouse was unresponsive, the 
hands and feet were secured to a styrofoam surface using push pins. THe mouse was 
oriented ventral side upwards, with limbs outstretched. The skin of the abdomen was 
then removed with dissecting scissors to expose the rib cage. The ribcage was then cut 
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 on the lateral aspects of the abdomen. Forceps were used to raise the ribcage, and 
dissecting scissors were used to disconnect the ribcage from the diaphragm and all 
other connective tissue to expose the heart and lungs. The ribcage was then fully 
removed. Microdissection forceps were then used to cradle and raise the heart out of 
thorax. A butterfly needle was then injected into the left ventricle of the heart. This 
needle was used to first slowly inject 12 ml of 1x PBS. (See appendix) The needle was 
then used again to perfuse 12 ml of 4% PFA. (See appendix)  Kidney, liver, lung, and 
spleen tissue was then extracted and left to fix overnight in 5 ml of 4% PFA at 4 degrees 
celsius. The head of the mouse was then removed. An incision was made in the skin at 
the base of the occipital bone. The skin was then peeled forward to expose the skull. 
The skull was cut at the base of the occipital bone and forward through the midline 
along the sagittal plane. The skull was then peeled to the side exposing the brain. 
Microdissection forceps were then used to lift the brain by its base from the skull. The 
cerebellum and olfactory bulb were often retrieved, but later removed. The brain was 
then fixed overnight in 5 ml of 4% PFA at 4 degrees celsius. 
 
Tissue Washing and Dehydrating: 
 
After the tissues were allowed to fix overnight in PFA, they were then washed 
using 0.1M Phosphate Buffer, or PB. (See appendix) Tissues were washed in 3 
sequential baths of PB, with each wash being no less than 1 minute. This step is 
important to remove the PFA as the fixation was finished, and in order to handle the 
brains the potentially carcinogenic PFA should be removed. After washing, brains were 
placed in 30% sucrose (See appendix) for dehydration at 4 degrees celsius. In order to 
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 slice the brains, they need to be flash frozen. In a fully hydrated brain, this would lyse 
the cells and render the tissue useless. Sucrose is used to create a concentration 
gradient that promotes the dehydration of the tissue, allowing the tissue to be flash 
frozen. These tissues should float on the sucrose, as when they are hydrated they 
should be less dense. As they dehydrate though, they become denser and sink. Once 
the tissue is at the bottom of the sucrose solution it should be ready for slicing. 
 
Microtome slicing: 
 
The sample tissues were then sliced on a freezing microtome. This device uses a 
wedge shaped blade with a fine edge to slice tissues. The vertical setting of the blade 
can be adjusted by a set distance, which allows for consistent slice thickness. The base 
plate of the microtome is preemptively chilled using dry ice. Tissues were then flash 
frozen on dry ice and mounted on the base plate using OST. This solution is viscous at 
room temperature, but freezes rapidly at colder temperatures, securing the tissue in 
place. Slices were then taken of the tissue sample at 30, 40, and 50 um in thickness. 40 
um proved to be the most reliable slice thickness while still being as thin as possible.  
For the liver, kidney, lung, and spleen, the orientation of the tissue was not a 
largely important factor in mounting. Brains, however, were sectioned to provide coronal 
cross sections. The cerebellum and olfactory bulbs were removed, and brains were 
mounted with ventral side upwards. Slices from all tissues were preserved in 3 ml of 0.1 
M PB in 24 well plates, each well containing between 3 and 6 slices. These cells were 
stored at 4 degrees celsius until staining. 
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 Immunohistochemistry: 
  
Tissues were then stained using immunohistochemistry. This process involves 
using antibodies to specific targets to attach fluorescent compounds to tissues for 
imaging. This process works by taking advantage of the multiple regions of an antibody. 
An antibody has both a variable and a conserved region. The variable region is different 
depending on the antigen that it is targeted against. The conserved region remains the 
same depending on the animal the antibody is derived from. By using two stages of 
antibodies, the cost of staining can be greatly reduced.  
The way this works is that the primary antibody applied is specific to an antigen. 
The antibody will then bind this antigen. The secondary antibody will be used to target 
the conserved animal region of the primary antibody. These secondary antibodies can 
be made with multiple kinds of fluorophores attached. Since they bind the conserved 
region of the primary antibody, they can be used in multiple different kinds of staining, 
conserving cost. The secondary staining also has an amplifying effect, meaning that 
even low primary levels of antibody binding can lead to a noticeable amount of 
fluorescence.  
The first step in staining the tissue using immunohistochemistry is to transfer the 
samples into a fresh 24 well plate with 0.3 ml of 0.1M PB per well. The PB was then 
decanted, and 0.3 ml of PBTGS (See appendix) was applied. PBTGS contains goat 
serum, and is responsible for blocking and permeabilizing the tissue. Permeabilization 
allows for larger molecules like antibodies to enter the cells of the tissue. Blocking using 
goat serum is used to prevent the nonspecific binding of the secondary antibody. Since 
18 
 goat serum is used in the blocking phase, secondary antibodies are all goat derived. 
The tissue was left to incubate at room temperature for 30 minutes to 1 hour. At the end 
of this process, PBTGS was decanted from the samples. 200 ul of primary antibody 
diluted in PBTGS were then applied to each well. Concentrations of these antibodies in 
PBTGS were dependent on the antibody used. (See appendix) For brain tissue, 
antibodies to CD11b and Iba1 were used. In liver tissue staining, antibodies to F480 
were used. Once primary antibodies were applied, tissues were covered and left to sit 
overnight on a rocker at room temperature.  
The next day, primary antibody solution was decanted. Tissues were washed 3x5 
minutes with 0.3 ml of 0.1M PB. 250 ul of secondary antibody, diluted 1:1000 in PBTGS, 
were then applied to each well. Antibodies selected were specific to the animal the 
primary was chosen from. (See appendix) The antibodies were also selected 
fluorophores that fluoresce at 488 nm, which results in a green fluorescence. Since 
these antibodies are light sensitive, they must be covered as much as possible. Tissues 
were incubated on the rocker at room temperature covered in tin foil for 1-2 hours. At 
the end of the incubation the secondary solution was decanted from the tissue. The 
samples were then washed 3x5 minutes with 0.3 ml of 0.1 M PB. Samples were then 
covered in tin foil then stored at 4 degrees celsius until plated.  
 
Plating: 
 
In order to visualize the stained slices, they had to first be mounted on a slide. 
Using a pipette with the tip cut to provide a wider opening, slices were moved from the 
well plate onto a microscope slide. Using a compound light microscope for better field of 
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 view, slices were spread onto the the slide using two paint brushes. It is important to 
make sure all of the slices are unfolded so the coverslip can lay flush and the tissues 
are all in the same horizontal plane. Excess liquid was decanted off the slide using a 
pipette and kimwipe. Slides were allowed to partially dry so that only the tissue 
remained moist. DAPI fluoroshield was then applied to both stain nuclei in the tissue, 
preserve the fluorescence of the antibody fluorophores, and to help anchor the tissue 
for coverslip mounting. After application of the coverslip, The edges of the coverslip 
were coated in clear nail polish to secure the coverslip and create a seal, sterilizing and 
preventing contaminants from entering the slide. Slides were then stored at -20 degrees 
celsius until ready for imaging.  
 
Imaging:  
 
Stained slides were then imaged using both confocal microscopy and 
epifluorescence microscopy. Epifluorescent microscopy is a technique that involves 
reflecting lower wavelength light from a high powered light source to shine through the 
slides. This is ideal for measuring tissue that is fluorescently tagged in the blue or green 
spectrums. Since both DAPI and the green fluorophores used in this experiment are of 
blue and green fluorescence respectively, this is an ideal method to quickly visualize the 
tagged tissue. Confocal microscopy has some advantages over this technique. This 
method uses lasers of specific wavelengths to excite the fluorescent labels. This can 
yield a much higher resolution image. However, in this experiment both techniques used 
showed nearly identical results. Since the main goal objective was to only count the 
number of microglial cells, both yielded sufficient resolution to do so. 
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Anylysis: 
 
The images acquired from microscopy were then analyzed in a program called 
FIJI, a modified version of the program ImageJ. This program allows for the splitting of 
fluorescent channels and modification of visual settings like contrast or brightness. This 
makes it easier to modify the image to accentuate cells for counting. The FIJI program 
also come equipped with a cell counting tool, reducing the probability of double counting 
or missing cells. Cell counts were done manually as opposed to using a program to 
assure that only cells were counted, and background interference was not attributed to 
the presence of cells.  
 
Results 
 
Depletion: 
 
The results of these experiments show very interesting and promising results for 
the cre-lox technique. Microglia cell counts were compiled from the various genotypes, 
and it appears evident that there is a significant reduction in microglia throughout to the 
brain in knockout genotype mice. (figure 1) With the average number of microglia per 
field of view in knockout mice being only 22, compared to the two control genotypes 
which boast over 150 microglia per field of view each, it can be seen that in these trials 
that there was a significant degrees comparing the genotypes. With the only variability 
between the subjects being the genotypes of the mice, it is a safe assumption that the 
difference is caused by the cre-lox mechanism. (Figure 1) When examining images of 
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 the tissues as well, it can be seen clearly that there is a marked reduction in both cortex 
and midbrain tissues. (figure 2) 
 
A.)         B.) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Depletion of microglia in desired genotypes of paradigm 1 mice, measuring 
microglia per field of view.  A.) Paradigm 1 cortex depletion. B.) Paradigm 1 midbrain 
depletion. 
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A.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Comparison of paradigm 1 brains of desired genotypes stained using DAPI 
(blue) and CD11b (green) antibodies. A.) Paradigm 1 tissue samples observed at 5x 
magnification. B.) Paradigm 1 tissue samples observed at 20x magnification.  
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Tissue macrophages: 
 
One important criteria in determining the success of this tool was the need to 
demonstrate that other macrophages in the body were not significantly affected by the 
application of this tool. For this, liver tissue was stained and imaged, and the number of 
macrophages were counted. The results from this show that there is almost no 
difference in the number of macrophages in these tissue samples. (figure 3) It is 
important to note that only liver staining proved viable for counting, so a generalization 
for all tissue macrophages cannot be made. However, it is significant to show that there 
was no reduction in the liver tissue. This 
provides strong support that the cre-lox system 
succeeds in selective elimination of microglia, 
however more testing should be performed to 
confirm this. The abundance of macrophages 
can be seen in images taken from both control 
and knockout tissues. Without counting, the 
difference between the two genotypes is 
almost indiscernible. (Figure 4) 
 
 
 
 
Figure 3: Comparison of tissue macrophage  
populations in liver samples taken from paradigm  
2 mice, measured in macrophages per field of view. 
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Figure 4: Comparison of paradigm 2 liver samples of knockout and control genotypes at 
at 20x magnifications, stained using DAPI (blue) and F480 (green) antibodies.  
 
 
Repopulation: 
 
A preliminary examination of repopulation was also performed by comparing the 
knockout genotypes from paradigms 1 and 2 in different regions of the brain. The 
reason for this comparison was to give some insight into how and where the process of 
repopulation in the brain may occur. It is important to note that the results from this 
cannot be said to be strongly indicative of and single result, and is only a test to provide 
a potential foothold for where to begin in future examinations. That being said, the 
results that were obtained are very interesting and if they are representative of a trend 
could potentially inform a great deal about where future experiments in this field need to 
be focused. When comparing the two knockout genotypes, both cortex and midbrain 
were examined. Before examining the samples from these tissues, there were no 
expectations on where the repopulation may be happening, if any. However, upon 
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 examination, the regions that needed to be compared become extremely evident. THe 
midbrain regions of both paradigms appeared completely devoid of microglia. However, 
in the paradigm 2 cortex, there was a consistent high density of microglia compared to 
the midbrain. (figure 5)The numbers found in these regions contested those of the 
control mice. (figure 5) This is an extremely interesting result, which warrants further 
investigation. Images from these tissues support the data acquired by cell counting. 
(Figure 6) 
 
A.) B.)  
 
  
 
 
 
 
 
 
 
 
C.) 
 
 
 
 
Figure 5: Depletion of microglia in knockout 
genotypes of mice from paradigms 1 and 2, 
measuring microglia per square um.  A.) Cortex 
microglia count. B.) Midbrain microglia count. C.) 
Combined microglia count. 
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A.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.) 
 
Figure 6: Comparison of knockout mice of paradigms 1 and 2 of cortex and midbrain 
tissue samples, stained using DAPI (blue) and CD11b (green) antibodies. A.) Cortex 
tissue samples from knockout paradigms. B.) Midbrain tissues from knockout 
paradigms. 
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Discussion 
 
The study of microglia in a healthy central nervous system is a field shrouded in 
enigma and uncertainty. There are many things that are simply not known about these 
unique cells, and many things that can only be speculated about. One thing that is 
certain, however, is that these cells are vitally important, and that their role in the 
healthy brain may still be underestimated. This experiment demonstrates a trial of a 
technique that could provide insight and answers to many of the questions that still need 
to be answered.  
The results from this experiment show promise in that the technique is likely 
effective. However, though the results are promising, more validation is needed. The 
cre-lox system is well established in it’s own right, a fortunate fact that may relieve some 
of the burden to prove it’s worth in this application. With all new techniques, however, 
there are many aspects that need to be tailored to the situation in which they are 
applied. During the process of this trial, there was a degree of troubleshooting that had 
to be performed to enhance the efficacy of the system. 
The first hurdle that needed to be overcome is increasing the survival rate of 
mice in the trial. In the early stages of this experiment, many mice were dieing before 
the retrieval timepoint. Others appeared sickly and weak as well. Trials were run where 
the remaining genotypes of each litter that weren’t desired for the experiment were 
injected with only corn oil, and no tamoxifen, to determine whether that was the 
problem. With an almost zero fatality rate for those mice, it was determined that perhaps 
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 the preparation of the tamoxifen was causing these fatalities. By changing the method 
of dissolution in the corn oil from sonication to incubation on a rotator, the survival rate 
became nearly 100% in all trials. It is possible that the sonication was shearing pieces 
of plastic from the inside of the eppendorf tube, which would then be harmful to the mice 
when injected. It’s also possible that the head from sonication could cause the alteration 
of the chemicals in solution to become toxic. A third possibility is that the sonication 
created free radicals in solution that would also be toxic to the subject. Any combination 
of these three effects could be possible, or there could be an unknown effect of 
sonication that rendered the solution harmful to the mice. 
Another issue to be confronted was the staining of tissue macrophages. While 
CD11b and Iba1 seemed to stain microglia extremely well, using them to stain the 
tissue macrophages proved less successful. Since F480 was used to stain liver 
macrophages in the past, it was implemented as the antibody of choice in this case as 
well. Though this was only shown to work in the liver in this experiment, future tests 
should provide more answers on how best to stain for tissue macrophages in 
conjunction with these techniques.  
With these two main issues being addressed, this experiment provides grounds 
for future experiments. One of the critical questions this technique is being designed to 
answer is where do microglia replenish from? Microglia have been seen to be dividing 
on occasion, however it has already been shown that the rate of repopulation is far too 
high to be attributed to an unmodified pattern of cellular division. (21) The results of the 
knockout comparison shed some light onto where studies may begin to examine these 
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 repopulation patterns. It appears that in cortex, specifically in the white matter tracts, 
there is a high density of repopulating microglia at later timepoints. Comparing the 
brains that were retrieved 2 days after last injection and brains retrieved 10 days after 
last injection, it appears that at some point between these two times repopulation began 
at a rapid rate.  
Based on these results, there are a host of future experiments that should be 
performed to narrow down this question. The first experiment that will be crucial to this 
is to generate a litter of mice that consists only of knockout genotypes. If there is not 
enough data at that time to establish this technique as effective in depopulating 
microglia, a litter of non knockout genotypes could be generated as a control 
comparison. The knockout litter would undergo a series of tamoxifen injections, and 
every day following the final injection a mouse should be retrieved and examined. This 
would provide a scale of time points showing an estimation of when and where 
repopulation will begin. This experiment could be performed again using shorter time 
points centered around the observed repopulation timepoints.  
Another experiment that should be performed is examining the depletion of 
microglia over time. This should be performed exactly as the previously described 
experiment, but mice should be retrieved starting on the first day of injection. This 
should provide information on where microglia are depleted first, and in which regions 
they remain the longest, if any. It would also be pertinent to examine how long it takes 
for tamoxifen without the knockout genotype present to affect the health of the subject. 
Over shorter time points there does not seem to be a drastic effect, however the 
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 long-term effects should be studied first hand to provide references when creating new 
protocols.  
Lastly, more trials should be performed to examine tissue macrophage colonies 
throughout the body to confirm that the technique does not disrupt other tissues. This 
can be done upon retrieval, but another possibility is to use punch biopsies to recover 
tissue from living specimens over the course of the trial. This would be invaluable data, 
as it comes as close to real time imaging in a host as our technology allows. 
With modern technology it is possible to observe many phenomena in real time. 
One avenue of approach may be to examine the CNS in real time using MRI 
technology. In it’s current state there are significant limitations though. It may be 
extremely difficult to get an accurate enough image to be able to count microglia, if it’s 
even possible. Though the technology may not be advanced enough yet, real time 
imaging of microglia in the brain will lend enormously to this field of research. With static 
images, it is very difficult to say for certain what these cells are doing at any given point 
in time. Growing these cells in vitro, as well, shows vastly different morphology from 
microglia found in vivo.  
Hindrances of technology aside, the current techniques should prove sufficient to 
answer many of the broader questions on the topic. While the field is still establishing 
many of these answers, the array of other research they may assist is large. For 
example, there are many speculations about how microglia are involved in diseases like 
alzheimer's. Techniques such as this may prove useful in manipulating alzheimer's 
systems to find out what role microglia actually perform in these diseases. This applies 
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 to conditions like schizophrenia as well, where microglia are shown to be exceedingly 
active. Studying their role in these neurological conditions may well inform how they 
may function in a healthy brain as well. As stated before, the studies of how microglia 
are involved in synaptic pruning and neuronal wiring are proving hot topics in the field, 
and will prove to be significant discoveries if confirmed and elucidated.  
 
Conclusions  
 
There are two major conclusions that can be drawn from the data provided in this 
experiment. The first is that the cre-lox system, when applied in this way, does have to 
potential to consistently eliminate microglia from the brain. The data shows a clear and 
drastic decrease in cell counts comparing the control and knockout genotypes which 
can be seen both through visualization and quantitation. This evidence is sufficient to 
advise further testing of the technique, and validates using this technique and 
supporting the results gained from doing so.  
The second major conclusion that can be drawn is that the cre-lox system does 
not severely affect tissue macrophages in the liver. This shows that when the technique 
is applied, specimens should retain normal function other than the disruption to the 
microglia population. This experiment should allow for the use of this technique with 
minimal concern as to the animal’s health other than the depletion of microglia.  
The last conclusion that should be drawn from this experiment is that though this 
technique works, there may still be ways to improve it. With new resources becoming 
available, some of these methods may rapidly become outdated or replaceable. It is 
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 important to continue adapting and perfecting the techniques used here, while still 
seeking out other techniques to improve the methodology. There are many more 
questions that need to be answered, but the utilization of the cre-lox system may prove 
invaluable in bringing to light the enigma that is the microglia.  
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 Appendix 
Appendix I: Genotyping Primers and Cycles  
JAX Cx3cr1 
CreER #Rxns 8 CycleName:  
Kapp 
Cycling  
Reaction   Cycling    
Reaction 
Component Volume (µl) Total Volume (µl) Step # 
Temp 
°C Time Note 
ddH2O 3.1 24.8 1 94 2 min - 
2X Taq RED 
Master Mix 6 48 2 94 20sec - 
20 uM 12266 0.3 2.4 3 65 15sec 
-0.5 C per 
cycle 
20 uM 14314 0.3 2.4 4 68 10sec - 
36 
 20 uM 16221 0.3 2.4 5 - - 
repeat steps 
2-4 for 10 
cycles 
DNA 2  6 94 15sec - 
   7 60 15sec - 
Total 12  8 72 10sec - 
Total w/out 
DNA 10 80 9 - - 
repeat steps 
6-8 for 28 
cycles 
   10 72 2 min - 
   11 10 - hold 
       
37 
 Expected 
Results: 
Mutant = 300 
bp      
 
Heterozygot
e = ~300 bp 
and 695 bp      
 
Wild type = 
695 bp      
 
 
CSF1R fl/fl #Rxns 14 
CycleName
:  sst cre  
Reaction   Cycling    
Reaction 
Component Volume (µl) 
Total Volume 
(µl) Step # 
Temp 
°C Time Note 
ddH2O 3.4 47.6 1 94 2 min  
2X Taq RED 
Master Mix 6 84 2 94 20sec  
16422 0.3 4.2 3 65 15sec 
-0.5 C per cycle 
decrease 
26825 0.3 4.2 4 68 10sec  
DNA 2  5   
repeat steps 2-4 for 
10 cycles 
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    6 94 15sec  
Total 12  7 60 15sec  
Total w/out 
DNA 10 140 8 72 10sec  
   9   
repeat steps 6-8 for 
28 cycles 
   10 72 2 min  
Expected 
Results: 
Mutant ~273 
bp 
 
11 10  hold 
 
Heterozygote 
= ~200 bp 
and 465 bp      
 
Wild type = 
193 bp      
 
Appendix II: Electrophoresis Gel Preparation 
1.5% Agarose Gels for the Gel Trays in the Schafer Lab 
(NB - these should make gels 0.5cm thick) 
7 x 10 cm (the tiny tray) 
30mL 1x TAE 
.45g Agarose 
7.5uL 1% EtBr 
Use the small flask, microwave in increments of 15 secs, check and swirl between 
(usually takes 45s total) 
 
15 x 15 cm (the smaller big tray) 
100mL 1x TAE 
1.5 g Agarose 
25uL 1% EtBr 
Use the larger flask, microwave in increments of 30 secs, check and swirl between 
(usually takes 90 - 120s total) 
39 
  
15 x 25 cm (the larger big tray) 
180mL 1x TAE 
2.7g Agarose 
45uL 1% EtBr 
Use the larger flask, microwave in increments of 30 secs, check and swirl between 
(usually takes 120 - 180s total) 
 
Appendix III: Tamoxifen Preparation 
Tamoxifen Catalogue Number: Sigma T5648-1G 
Concentration: 50 mg/kg, 50ug/ul 
Tamoxifen prepared in 5 ml eppendorf tube 
Stock solution generated from Tamoxifen diluted into corn oil. 
Add tamoxifen to 20 ug/ul, dissolve overnight on rotator in incubator. 
Dilute Stock solution to a concentration of 50ug/50ul to create working solution. 
Appendix IV: Avertin Protocol  
Materials: 
● 2,2,2-tribromoethanol (97%) (Avertin) 
● Tert-amyl alcohol, reagent grade 
 
Preparation of stock solution 
1. Add 6.2 ml tert-amyl alcohol to 10g of Avertin.  Concentration of stock will be 
1.61 g/ml 
2. Stir Avertin on a magnetic stirrer overnight. 
3. Store stock in dark bottle, tightly capped, and at room temperature.  The stock 
solution is stable for 6-12 months. 
 
Preparation of 2.5% Working Solution (To make 50ml) 
1. Recommended: pre-treat a 50ml graduated cylinder with 10% HCL to remove 
detergent residue.  Thoroughly rinse the cylinder with Milli-Q water. 
2. Add 49.2ml 1X PBS to the cylinder. 
3. Add 0.78ml of Avertin stock solution. 
4. Wrap with aluminum foil to exclude light. 
5. Stir slowly on heat overnight to dissolve Avertin stock solution. 
6. Filter the working solution through a 0.2 micrometer filter.  
7. Store at 4​°C.  ​Working solution is stable for 6 months. 
 
Appendix V: Stock Solutions 
Solutions 
10X Phosphate Buffered Saline (PBS) 
For 1000mL (1L):  
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 To 900 mL ultrapure water on stirrer add: 
80g NaCl (sodium chloride) 
2.0g KCl (potassium chloride) 
14.4 g Na​2​HPO​4 ​(dibasic phosphate) 
2.4 g KH​2​PO​4 ​(monobasic potassium phosphate).  
Once dissolved adjust pH to 7.4 with 10N HCl. Adjust volume to 1L with additional distilled 
ultrapure water. 
 
1XPBS 
For 1000mL (1L): 100 mL 10X PBS and fill to 1000mL with ultrapure water. 
 
0.2M Monobasic Phosphate Buffer (PB-A) 
For 500 mL: Measure 13.8 g Monobasic Phosphate into 400 mL ultrapure water.  
Stir over low heat.  
Once dissolved, fill to 500 mL with ultrapure water. 
 
0.2M Dibasic Phosphate Buffer (PB-B) 
For 1000 mL (1L):  
Measure 28.4 g Dibasic Phosphate into 900 mL ultrapure water. Stir.  
Once dissolved, fill to 1000 mL with ultrapure water. 
 
0.1M Phosphate Buffer (PB) 
For 1000 mL (1L):  
95 mL PB-A 
405 mL PB-B 
Fill to 1000 mL with ultrapure water 
 
10% TritonX 100 (TX-100) Stock 
For 10 mL: 
Add 1 mL TX-100 to 9mL 0.1M PB 
Store at RT 
 
PBTGS  
For 5 mL: 
-Add 0.5 mL goat serum and 150ul 10%TX-100 to a 15 mL falcon tube 
-Fill tube to 5 mL with 0.1M PB. 
*Store at 4 degree and use within 3 days. 
 
Appendix VI: PFA Preparation 
4% PFA diluted in sterile filtered PBS: 
16% EM grade diluted in PBS to 4%: EMS catalog #30525-89- 4. 
 
Appendix VII: Antibodies 
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 Primary Antibodies 
Anti Iba1 Glia Box 1 5 Abcam ab139590 Chicken 1:1000 
Anti Iba1 Glia Box 1 6 Abcam ab107159 Goat 1:1000 
Anti Iba1   abcam ab5076 Goat 1:1000 
Anti Iba1 Glia Box 1 2 Wako Chemicals 019-19741 Rabbit 1:500 
Anti Mouse 
CD11b Glia Box 1 1 AbD Serotec MCA711G Rat 1:200 
 
Secondary Antibodies 
 
Goat anti-Guinea Pig 
IgG (H+L) Secondary 
Antibody, Alexa Fluor 
488 conjugate   Thermo Fisher A-11073 Goat 1:1000 
Goat anti-Mouse IgG 
(H+L) Secondary 
Antibody, Alexa Fluor 
488 conjugate   Thermo Fisher A-11029 Goat 1:1000 
Goat anti-Rabbit IgG 
(H+L) Secondary 
Antibody, Alexa Fluor 
488 conjugate   Thermo Fisher A-11034 Goat 1:1000 
Goat anti-Rat IgG (H+L) 
Secondary Antibody, 
Alexa Fluor 488 
conjugate   Thermo Fisher A-11006 Goat 1:1000 
Donkey anti-Chicken 
(H+L) Alexa Fluor 488 
conjugate 
Fluorescent 
Protein Box 
1 11 Sigma SAB4600031 Donkey 1:1000 
Donkey anti-Chicken 
IgY(IgG) (H+L) Alexa 
Fluor 488-conjugate 
Alexa 488 
Box #1  
Jackson 
ImmunoResearch 703-545-155 Donkey 1:1000 
Donkey anti-Goat IgH 
H&L Alexa Fluor 488 
Alexa 488 
Box #1      
Goat anti-Guinea Pig 
IgG (H+L) Secondary 
Antibody, Alexa Fluor 
594 conjugate   Thermo Fisher A-11076 Goat 1:1000 
Goat anti-Mouse IgG 
(H+L) Secondary 
Antibody, Alexa Fluor 
594 conjugate   Thermo Fisher A-11032 Goat 1:1000 
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 Goat anti-Rabbit IgG 
(H+L) Secondary 
Antibody, Alexa Fluor 
594 conjugate   Thermo Fisher A-11037 Goat 1:1000 
Goat anti-Rat IgG (H+L) 
Secondary Antibody, 
Alexa Fluor 594 
conjugate   Thermo Fisher A-11007 Goat 1:1000 
Donkey anti-Goat (H+L) 
Secondary Antibody, 
Alexa Fluor 594 
conjugate   Thermo Fisher A11058 Donkey 1:1000 
Goat anti-mouse IgM (µ 
chain) Secondary 
Antibody, Alxa Fluor 
494 conjugate   Thermo Fisher A21044 Goat 1:1000 
Goat anti-Guinea Pig 
IgG (H+L) Secondary 
Antibody, Alexa Fluor 
647 conjugate   Thermo Fisher A-21450 Goat 1:1000 
Goat anti-Mouse IgG 
(H+L) Secondary 
Antibody, Alexa Fluor 
647 conjugate   Thermo Fisher A-21236 Goat 1:1000 
Goat anti-Rabbit IgG 
(H+L) Secondary 
Antibody, Alexa Fluor 
647 conjugate   Thermo Fisher A-21245 Goat 1:1000 
Goat anti-Rat IgG (H+L) 
Secondary Antibody, 
Alexa Fluor 647 
conjugate   Thermo Fisher A-21247 Goat 1:1000 
Alexa Fluor® 647 
AffiniPure Donkey 
Anti-Guinea Pig IgG 
(H+L)   
Jackson 
ImmunoResearch 706-605-148 Donkey 1:1000 
Donkey anti-Goat IgG 
(H+L) Secondary 
Antibody, Alexa 647 
conjugate 
Alexa 647 
Box #1  Invitrogen A21447 Donkey 1:1000 
Anti-Mouse IgG (H+L) 
HRP 
HRP-Conju
gated Box1 4 Bio-Rad 170-6516 Goat 1:10000 
Anti-Rabbit IgG (H+L) 
Horseradish 
Peroxidase-conjugated 
HRP-Conju
gated Box1 3 Bio-Rad 170-6515 Goat 1:10000 
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 Goat IgG Horseradish 
Peroxidase-conjugated 
HRP-Conju
gated Box1 1 R&D Systems, Inc. HAF005 Donkey 1:10000 
Rat IgG Horseradish 
Peroxidase-conjugated 
HRP-Conju
gated Box1 2 R&D Systems, Inc. HAF109 Goat 1:10000 
 
 
Appendix VIII: Tissue Digest 
Reagents: 
 
25mM NaOH/0.2mM EDTA 
20uL 0.5M EDTA 
125uL 10M NaOH 
50mL H2O 
pH should be approx 12 
 
40mM Tris HCl 
242.28mg Tris Base 
15-25mL H2O 
pH to 5.5 with HCl 
add H2O to volume of 50mL 
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